Last10K.com

American Brivision (ABVC) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2020

SEC Filings

ABVC Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

ABVC Annual Reports

ABVC Quarterly Reports

ABVC Corporate News

ABVC Registration of Securities

American Brivision

HISTORY TOOLS
CIK: 743532 Ticker: ABVC
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2020
Jun. 26, 2020
Document and Entity Information [Abstract]  
Entity Registrant NameAmerican BriVision (Holding) Corp 
Entity Central Index Key0001173313 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Document Type10-Q 
Document Period End DateMar. 31, 2020 
Document Fiscal Period FocusQ1 
Document Fiscal Year Focus2020 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Shell Companyfalse 
Entity Current Reporting StatusYes 
Entity Emerging Growth Companyfalse 
Entity Filer Number333-91436 
Entity Interactive Data CurrentYes 
Entity Incorporation State Country CodeNV 
Entity Common Stock, Shares Outstanding 19,488,168

View differences made from one quarter to another to evaluate American Brivision's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Brivision.

Continue

Assess how American Brivision's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Brivision's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows (Unaudited)
Consolidated Statements Of Operations (Unaudited)
Consolidated Statements Of Stockholders' Equity (Deficit) (Unaudited)
Bank Loans
Bank Loans (Details 1)
Bank Loans (Details Textual)
Bank Loans (Details)
Bank Loans (Tables)
Business Combination
Business Combination (Details Textual)
Business Combination (Details)
Business Combination (Tables)
Collaborative Agreements
Collaborative Agreements (Details)
Convertible Notes Payable
Convertible Notes Payable (Details)
Equity
Equity (Details Textual)
Equity (Details)
Equity (Tables)
Inventory
Inventory (Details)
Inventory (Tables)
Lease
Lease (Details 1)
Lease (Details 2)
Lease (Details Textual)
Lease (Details)
Lease (Tables)
Long-Term Investments
Long-Term Investments (Details 1)
Long-Term Investments (Details 2)
Long-Term Investments (Details 3)
Long-Term Investments (Details 4)
Long-Term Investments (Details 5)
Long-Term Investments (Details Textual)
Long-Term Investments (Details)
Long-Term Investments (Tables)
Loss Per Share
Loss Per Share (Details)
Loss Per Share (Tables)
Notes Payable
Notes Payable (Details)
Organization And Description Of Business
Organization And Description Of Business (Details)
Property And Equipment
Property And Equipment (Details Textual)
Property And Equipment (Details)
Property And Equipment (Tables)
Related Parties Transactions
Related Parties Transactions (Details 1)
Related Parties Transactions (Details 2)
Related Parties Transactions (Details 3)
Related Parties Transactions (Details Textual)
Related Parties Transactions (Details)
Related Parties Transactions (Tables)
Short-Term Loan
Short-Term Loan (Details)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Textual)
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)

Material Contracts, Statements, Certifications & more

American Brivision provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Certification
Exhibit 31.2: Certification
Exhibit 32.1: Certification
Exhibit 32.2: Certification
Ticker: ABVC
CIK: 1173313
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-20-016186
Submitted to the SEC: Mon Jun 29 2020 6:56:25 PM EST
Accepted by the SEC: Tue Jun 30 2020
Period: Tuesday, March 31, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/abvc/0001213900-20-016186.htm